Investitionsthese
Carduso Capital invests in technology-driven companies rooted in the Groningen region, leveraging academic research (UG/UMCG) to address clear market needs. Focus on long-term partnerships, active management support, and scalable returns.
Investitionsphase
Early-stage spin-offs, startups, and established companies (proof of concept + prototype preferred; investments range from €100K to €5M).
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Innovative technology companies with strong ties to University of Groningen (UG) and University Medical Centre Groningen (UMCG); early-stage spin-offs, startups, and established companies expanding on research and technology.
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
€100.000 - €5.000.000
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
Investment Team (10)
B
Bart Jan Korteling
Expert panel - Medical device expert
F
Frits Kok
Partner
H
Hans Biemans
Committee of Recommendation - vz President RUG
H
Harm Wesseling MBA
Expert panel - Directeur ICT & Medische Techniek Martini Ziekenhuis & Voorzitter ICT Board Santeon
H
Henk Snapper
Committee of Recommendation - Member Board of Directors UMCG
J
Jouke de Vries
Committee of Recommendation - President RUG
K
Koos Koops
Partner
P
Prof. Dr. Lubbert Dijkhuizen
Expert panel - Hoogleraar Microbiologie & Initiatiefnemer en medeoprichter van het “Carbohydrate Competence Centre" (CCC)
R
Robert Polano
Partner
T
Ton Rijnders
Expert panel - Scientific Director of Top Institute Pharma
